Nutex Health Inc. (NUTX)
| Market Cap | 968.29M |
| Revenue (ttm) | 981.20M |
| Net Income (ttm) | 120.57M |
| Shares Out | 7.07M |
| EPS (ttm) | 17.98 |
| PE Ratio | 7.62 |
| Forward PE | 21.06 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 217,332 |
| Open | 139.99 |
| Previous Close | 142.34 |
| Day's Range | 131.63 - 144.49 |
| 52-Week Range | 28.12 - 184.28 |
| Beta | 2.00 |
| Analysts | Strong Buy |
| Price Target | 252.50 (+84.41%) |
| Earnings Date | Nov 19, 2025 |
About NUTX
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatie... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for NUTX stock is "Strong Buy." The 12-month stock price target is $252.5, which is an increase of 84.41% from the latest price.
News
NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5% Net income attributable to Nutex Health Inc. of $59.0 m...
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 217.5% Net income attributable to Nutex Health Inc. of $3.5 million for th...
NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 mi...
NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS
FULL YEAR 2024 HIGHLIGHTS: Total revenue of $479.9 million for the year 2024 versus $247.6 million for the year 2023, an increase of 93.8% Net income attributable to Nutex Health Inc. of $52.1 million...
NUTEX HEALTH PROVIDES CORPORATE UPDATE
Significant Year-over-Year Growth in Patient Volume and Cash Collections HOUSTON , Oct. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, in...
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
NUTX Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 21st Deadline SAN FRANCISCO , Oct. 17, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of m...
NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Health Investors to Contact the Firm Before the October 21st Deadline
The complaint alleges Nutex misled investors by concealing fraudulent HaloMD arbitration practices, weak controls, and misstated stock-based liabilities.
NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired s...
NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Investors to Contact the Firm Before the October 21st Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired ...
Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
HOUSTON , Oct. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro...
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements – Hagens Berman
SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-ac...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
HOUSTON , Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art mic...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2025 in Nutex Health Inc. Lawsuit - NUTX
NEW YORK , Sept. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Nutex Health Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
Shareholders who lost money in shares of Nutex Health Inc. (NASDAQ: NUTX) Should Contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline is October 21, 2025 NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is informing investors about a class action lawsuit against Nutex Hea...
Nutex Health Inc. (NUTX) Q2 2025 Earnings Call Transcript
Nutex Health Inc. (NASDAQ:NUTX) Q2 2025 Earnings Conference Call August 25, 2025 10:30 AM ET Company Participants Jon C. Bates - Chief Financial Officer Michael Chang - Chief Medical Officer Thomas T...
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Lawsuit
NEW YORK , Aug. 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Nutex Health In...
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements – Hagens Berman
SAN FRANCISCO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- A new class-action lawsuit alleges that Nutex, a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing fi...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Nutex Health Inc. (NUTX)
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of T...
Nutex Health's Quiet Buy-The-Dip Setup After A Blowout Quarter
Nutex Health is disrupting ER care with micro-hospitals, delivering high-margin, profitable growth, and winning 80%+ of arbitration cases against insurers. Q2 results were a blowout: revenue up 221% Y...
NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
HOUSTON , Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micr...
Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report – Hagens Berman
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop fo...